According to latest market research report "Syringes Market Size & Share by Type (General & Specialized Syringes (insulin, tuberculin)), Usability (Sterilizable/reusable (hypodermic, oral) & Disposable Syringes (conventional, safety, prefilled)), Material (Glass & Plastic Syringes) - Global Forecast to 2021", the overall market for syringes is expected to reach $15.99 billion by 2021 from $10.56 billion in 2016, at a CAGR of 8.7% during the forecast period.
Browse 70 market data tables and 42 figures spread through 129 pages and in-depth TOC on “Syringes Market”
Early buyers will receive 10% customization on reports.
This report studies the global market of syringes over the forecast period of 2016 to 2021. the report analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Europe, Asia-Pacific, and the Rest of the world (RoW).
Key factors such as high prevalence of chronic diseases across the globe, rising geriatric population, increasing adoption of safety syringes, technological advancements, and increasing demand for vaccines are supporting the growth of this market. However, the high cost of safety syringes and increasing incidence of needle stick injuries are the major challenges in this market.
On the basis of usability, the global market of syringes is segmented into two broad categories, namely, sterilizable/reusable syringes and disposable syringes. The disposable syringes market is estimated to command the larger share of the global syringes market in 2016. The large share of this segment can be attributed to the increasing use of injectables as a mode of drug delivery, growing aging population, high infection risks associated with reusable syringes, and increasing inclination towards self-administration.
On the basis of type, the global market of syringes is segmented into general syringes and specialized syringes. The general syringes segment holds a larger share in the market. The global specialized syringes segment is expected to grow at the higher rate from 2016 to 2021. Specialized syringes allow for the accurate delivery of drugs by overfilling or under filling, which is a key reason for its growing adoption among users. In addition, other factors such as the increasing use of injectables as a mode of drug delivery and increasing inclination towards self-administration are driving the growth of the specialized syringes market across the globe.
On the basis of material, the global market of syringes is further segmented into glass syringes and plastic syringes. The glass syringes segment is expected to account for a larger share of the syringes market in 2016. Glass syringes are more resistive and reduce the chances of the syringe material reacting with the fluid. These syringes can also be sterilized and reused. On the other hand, the plastic syringes segment is expected to witness higher growth during the forecast period. Factors such as rising awareness about blood-borne infections and increasing inclination towards self-administration are driving the growth of the plastic syringes segment in the global market.
As of 2016, North America holds the largest share of the global market, followed by Europe. However, the Asia-Pacific market is expected to grow at the highest CAGR of 9.3% from 2016 to 2021. A number of factors such as increasing technological advancement, rising focus of global players on the region, growing number of healthcare facilities, favorable regulatory policies for the approval of new injectables, and rapid growth in the aging population are propelling the growth of the market in the region are propelling the growth of the Asia-Pacific syringes market.
Becton, Dickinson and Company (U.S.), Terumo Corporation (Japan), Medtronic plc (Ireland), Smiths Medical (U.S.), B. Braun Medical Inc. (U.S.), NIPRO Corporation (Japan), Hindustan Syringes & Medical Devices Limited (India), Gerresheimer AG (Germany), SCHOTT AG (Germany), and CODAN Medizinische Geräte GmbH & Co KG (Germany) are some of the key players operating in the syringes market.
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Mr. Shelly Singh
630 Dundee Road
Northbrook, IL 60062
USA : 1-888-600-6441
Email: [email protected]